Fresh Tracks Therapeutics Valuation
| FRTXDelisted Stock | USD 0.78 0.09 10.34% |
Fresh Tracks is overvalued. Fresh Tracks Therapeutics shows a prevailing Real Value of $0.64 per share. The current price of the firm is $0.78. Our model computes the value of Fresh Tracks Therapeutics from reviewing the firm fundamentals such as Shares Outstanding of 5.97 M, profit margin of (0.89) %, and Current Valuation of (4.04 M) as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Fresh Tracks' price fluctuation is very steady at this time. Calculation of the real value of Fresh Tracks Therapeutics is based on 3 months time horizon. Increasing Fresh Tracks' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Fresh Tracks is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresh Pink Sheet. However, Fresh Tracks' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.78 | Real 0.64 | Hype 0.78 |
The intrinsic value of Fresh Tracks' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresh Tracks' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresh Tracks Therapeutics helps investors to forecast how Fresh pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresh Tracks more accurately as focusing exclusively on Fresh Tracks' fundamentals will not take into account other important factors: Fresh Tracks Total Value Analysis
Fresh Tracks Therapeutics is currently anticipated to have valuation of (4.04 M) with market capitalization of 4.84 M, debt of 49 K, and cash on hands of 14.48 M. The negative valuation of Fresh Tracks may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Fresh Tracks fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(4.04 M) | 4.84 M | 49 K | 14.48 M |
Fresh Tracks Investor Information
The company has price-to-book (P/B) ratio of 0.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresh Tracks Therapeutics recorded a loss per share of 2.32. The entity last dividend was issued on the 3rd of September 2019. The firm had 1:45 split on the 5th of July 2022. Based on the key indicators related to Fresh Tracks' liquidity, profitability, solvency, and operating efficiency, Fresh Tracks Therapeutics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Fresh Tracks Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fresh Tracks has an asset utilization ratio of 67.6 percent. This suggests that the Company is making $0.68 for each dollar of assets. An increasing asset utilization means that Fresh Tracks Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Fresh Tracks Ownership Allocation
Fresh Tracks Therapeutics shows 11.62 percent of its outstanding shares held by insiders and 8.96 percent owned by other corporate entities.Fresh Tracks Profitability Analysis
The company reported the previous year's revenue of 6.94 M. Net Loss for the year was (21.1 M) with loss before overhead, payroll, taxes, and interest of (27.83 M).About Fresh Tracks Valuation
Our relative valuation model uses a comparative analysis of Fresh Tracks. We calculate exposure to Fresh Tracks's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fresh Tracks's related companies.Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
8 Steps to conduct Fresh Tracks' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fresh Tracks' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fresh Tracks' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Fresh Tracks' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Fresh Tracks' revenue streams: Identify Fresh Tracks' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Fresh Tracks' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Fresh Tracks' growth potential: Evaluate Fresh Tracks' management, business model, and growth potential.
- Determine Fresh Tracks' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fresh Tracks' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Fresh Tracks Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Fresh Pink Sheet
If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |